Vice Health and Wellness Valuation
Is Z24 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of Z24 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate Z24's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate Z24's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for Z24?
Key metric: As Z24 barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.
| What is Z24's PB Ratio? | |
|---|---|
| PB Ratio | n/a |
| Book | US$183.53k |
| Market Cap | US$159.90k |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does Z24's PB Ratio compare to its peers?
| Company | Forward PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 4.9x | ||
531211 Wellness Noni | 2.6x | n/a | ₹22.4m |
CLAI Cel AI | 0.2x | n/a | UK£316.2k |
HMPLY Hemply Balance Holding | 5.3x | n/a | SEK 6.3m |
HILL Hill | 11.4x | n/a | CA$787.9k |
Z24 Vice Health and Wellness | n/a | n/a | €218.8k |
Price-To-Book vs Peers: Insufficient data to calculate Z24's Price-To-Book Ratio vs. peers for valuation analysis.
Price to Book Ratio vs Industry
How does Z24's PB Ratio compare vs other companies in the European Personal Products Industry?
| 4 Companies | Price / Book | Estimated Growth | Market Cap |
|---|---|---|---|
| 4 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Book vs Industry: Insufficient data to calculate Z24's Price-To-Book Ratio vs. industry for valuation analysis.
Price to Book Ratio vs Fair Ratio
What is Z24's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | n/a |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate Z24's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
L'Oréal
€176.0b
Through its subsidiaries, manufactures and sells cosmetic products for women and men worldwide.
LOR
€329.75
7D
1.4%
1Y
-23.3%
Cheerwin Group
HK$2.5b
An investment holding company, manufactures and trades household insecticides and repellents, household cleaning, air care, personal care, pets and pet products, and other products in the People’s Republic of China.
1RQ
HK$0.21
7D
-2.8%
1Y
26.5%
Revolution Beauty Group
UK£39.3m
Engages in the development, production, wholesale, and retail of beauty products in the United Kingdom, the United States, and internationally.
8UA
UK£0.15
7D
-7.4%
1Y
-45.3%